Obagi Medical saw revenue growth and performance improvements driven by international markets and breakthrough innovation. Milk Makeup had mixed results, with growth in the U.S. but softer performance internationally. Waldencast updated its guidance for 2025, focusing on long-term growth and strategic initiatives. The company also completed the sale of the Obagi Japan trademark to strengthen its balance sheet. Waldencast reported stable net revenue performance and contrasted results between its brands in Q2 2025. Net revenue grew by 5.6% to $66.8 million with an Adjusted EBITDA Margin of 5.0%. In Q3 2025, Obagi Medical showed double-digit growth, while Milk Makeup faced challenges in international markets, resulting in a decline in net revenue. Waldencast is conducting a strategic review to maximize shareholder value, with Lazard as a financial advisor. The company is focused on improving its balance sheet and sharpening its strategic focus. In H1 2025, Waldencast saw a 0.5% increase in net revenue to $132.3 million, but also reported a net loss of $185.2 million due to impairment charges. Adjusted EBITDA was $7.7 million, 760 basis points lower than the previous year. Obagi Medical and Milk Makeup both experienced changes in net revenue and Adjusted EBITDA. In Q3 2025, Waldencast reported a 3.4% decrease in net revenue to $67.8 million. Obagi Medical saw growth in strategic channels, while Milk Makeup faced challenges due to a lull in marketing support. Waldencast maintains a limited increase in cost of goods due to changes in the tariff environment. The company continues to focus on long-term growth and sustainability. Waldencast operates as a global multi-brand beauty and wellness platform, focusing on purpose-driven brands. Obagi Medical and Milk Makeup are key brands under the Waldencast platform, known for their innovative products and clean ingredients. Waldencast advises caution regarding forward-looking statements, highlighting risks and uncertainties that could impact future performance. The company emphasizes the importance of GAAP financial measures and provides non-GAAP metrics for additional insight into its performance.

Read more at GlobeNewswire: Waldencast Announces Q2 2025 Results and Provides Q3 2025